Montek Plus Tablet is a fixed-dose combination product containing bambuterol, a beta-2 agonist, and montelukast, a leukotriene receptor antagonist, in a single tablet formulation. Each tablet contains 10mg of bambuterol and 10mg of montelukast. This combination therapy is indicated for the treatment of asthma and chronic obstructive pulmonary disease (COPD) patients requiring bronchodilator therapy. Montek Plus Tablet offers a unique combination of beta-2 agonist and leukotriene antagonist mechanisms of action, providing a comprehensive approach to bronchospasm management. The bambuterol component provides bronchodilation, while the montelukast component inhibits leukotriene-mediated bronchoconstriction. This fixed-dose combination therapy simplifies treatment regimens and provides a more convenient dosing schedule for patients. Additionally, Montek Plus Tablet has been shown to improve lung function, reduce asthma exacerbations, and enhance patient quality of life.

Dosage & How to Use